PHARMACOGENETICS TESTING MENU
|
|
- Rosa Miller
- 5 years ago
- Views:
Transcription
1 PHARMACOGENETICS TESTING MENU
2 Pharmacogenetics and the Patient Seeking Recovery Pharmacogenetics, as the name suggests, refers to the combined study of medications and inherited genetic traits. The manner by which medications are processed in the body, known as metabolic pathways, will vary from person to person according to each individual s DNA. Why does this matter? These common variations lead to differences in the ways medications affect individuals. Our genetic makeup determines the nature of the drug-metabolizing enzymes in the liver, the method by which medications are absorbed, distributed, metabolized, eliminated from body, and the receptors upon which medications work or fail to work. Even members of the same family will sometimes react very differently to the same drug, with one person receiving an inadequate dose and another afflicted with toxicity. Pharmacogenetic testing will guide the physician in selecting the right dose for the right medication, getting it right the first time. How Common Are Medication Failures? Failure rates are surprisingly high with commonly prescribed medications: Antidepressants (SSRIs) 38% failure Asthma drugs 40% failure Diabetes drugs 43% failure Alzheimer s drugs 70% failure Cancer medications 75% failure For this reason, the FDA now includes pharmacogenetic information to identify significant genetic markers on the labels of many medications. This information includes dosing guidance, risk for adverse reactions, and drug interactions for medications such as citalopram, risperidone, and others commonly used in the addiction treatment environment. Are there other concerns unique to Addiction Treatment? The patients we serve, because they have endured the effects of the powerful substances they abuse, will very commonly have accompanying physiological and behavioral comorbidities. It is critical that their physicians know how their patient will process the medication (pharmacokinetics) and what that medication will do to the patient (pharmacodynamics). Furthermore, because our focus is the needs of patients seeking recovery, our testing can offer insights into why patients seek particular substances to abuse. Pharmacogenetics and our understanding of the physiology of addiction (such as the dopamine tone and reward system, receptor function, etc.) can illuminate why some patients are compelled to seek stimulants vs. depressants. Our reporting can offer your team choices in treatment suited to each patient s unique needs.
3 Pain & Psychiatry Panel (Comprehensive) This panel provides a comprehensive test for all the pain and psychiatric medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Furthermore, this panel provides a risk assessment for Tardive Dyskinesia, Hyperprolactinemia, and weight gain for patients taking an antipsychotic medication, as well as a risk factor for inadequate antidepressant response. DRUG NAME TRADE NAME CATEGORY GENES RESPONSIBLE Amphetamine Adderall Anti-ADHD COMT Atomoxetine Strattera Anti-ADHD CYP2D6 Clonidine Catapres, Kapvay, Duraclon, Nexiclon Anti-ADHD CYP2D6 Dexmethylphenidate Focalin Anti-ADHD COMT Dextroamphetamine Dexedrine, ProCentra, Dextrostat Anti-ADHD COMT Lisdexamfetamine Vyvanse Anti-ADHD COMT Methylphenidate Daytrana, Concerta, Methylin, Aptensio, Ritalin Anti-ADHD COMT Bupropion Wellbutrin, Zyban, Aplenzin Antiaddictive ANKK1/DRD2, CYP2B6 Naltrexone Vivitrol, Revia Antiaddictive OPRM1 Carbamazepine Tegretol, Carbatrol Anticonvulsant CYP3A4, 5 Fosphenytoin Cerebyx Anticonvulsant CYP2C9 Lacosamide Vimpat Anticonvulsant CYP2C19 Phenobarbital Luminal Anticonvulsant CYP2C19 Phenytoin Phenytek, Dilantin Anticonvulsant CYP2C9 Primidone Mysoline Anticonvulsant CYP2C9, CYP2C19 Zonisamide Zonegran Anticonvulsant CYP2C19 Donepezil Aricept Antidementia CYP2D6 Galantamine Razadyne Antidementia CYP2D6 Mirtazapine Remeronsoltab, Remeron Antidepressant - Atypical CYP2D6 Nefazodone Serzone Antidepressant - Atypical CYP2D6 Vortioxetine Brintellix Antidepressant - Atypical CYP2D6 Desvenlafaxine Pristiq Antidepressant - SNRI CYP2D6 Duloxetine Cymbalta Antidepressant - SNRI CYP2D6, CYP1A2 Venlafaxine Effexor Antidepressant - SNRI CYP2D6 Citalopram Celexa Antidepressant - SSRI CYP2C19, GRIK4, HTR2A Escitalopram Lexapro Antidepressant - SSRI CYP2C19 Fluoxetine Prozac, Sarafem Antidepressant - SSRI CYP2D6 Fluvoxamine Luvox Antidepressant - SSRI CYP2D6 Paroxetine Paxil, Pexeva, Brisdelle Antidepressant - SSRI CYP2D6 Sertraline Zoloft Antidepressant - SSRI CYP2C19 Vilazodone Viibryd Antidepressant - SSRI CYP3A4 Amitriptyline Vanatrip, Elavil Antidepressant - TCA CYP2D6, CYP2C19 Amoxapine Asendin Antidepressant - TCA CYP2D6 Clomipramine Anafranil Antidepressant - TCA CYP2D6, CYP2C19 Desipramine Norpramine Antidepressant - TCA CYP2D6
4 Pain & Psychiatry Panel (Comprehensive) DRUG NAME TRADE NAME CATEGORY GENES RESPONSIBLE Doxepin Silenor, Prudoxin, Zonalon Antidepressant - TCA CYP2D6, CYP2C19 Imipramine Tofranil Antidepressant - TCA CYP2D6, CYP2C19 Maprotiline Ludiomil Antidepressant - TCA CYP2D6 Nortriptyline Aventyl, Pamelor Antidepressant - TCA CYP2D6 Protriptyline Vivactil Antidepressant - TCA CYP2D6 Trimipramine Rhotrimine, Stangyl, Surmontil Antidepressant - TCA CYP2D6, CYP2C19 Aripiprazole Abilify Antipsychotic CYP2D6 Brexpiprazole Rexulti Antipsychotic CYP2D6 Chlorpromazine Thorazine Antipsychotic CYP2D6 Clozapine FazaClo, Clozaril Antipsychotic CYP2D6, CYP1A2, HTR2A, HTR2C Fluphenazine Prolixin Antipsychotic CYP2D6 Haloperidol Haldol Antipsychotic CYP2D6 Iloperidone Fanapt Antipsychotic CYP2D6 Olanzapine Zyprexa Antipsychotic CYP2D6, CYP1A2, HTR2C Paliperidone Invega Antipsychotic CYP2D6 Perphenazine Trilafon Antipsychotic CYP2D6 Pimozide Orap Antipsychotic CYP2D6 Quetiapine Seroquel Antipsychotic CYP3A4, 5 Risperidone Risperdal Antipsychotic CYP2D6, HTR2C, ANKK1/DRD2 Tetrabenazine Xenazine Antipsychotic CYP2D6 Thioridazine Mellaril Antipsychotic CYP2D6 Trazodone Desyrel, Oleptro Antipsychotic CYP3A4 Ziprasidone Zeldox, Zipwell, Geodon Antipsychotic CYP3A4 Alprazolam Xanax Benzodiazepine CYP3A4, 5 Clobazam Onfi Benzodiazepine CYP2C19 Diazepam Diastat, Valium Benzodiazepine CYP2C19 Lorazepam Ativan Benzodiazepine UGT2B15 Oxazepam Serax Benzodiazepine UGT2B15 Carisoprodol Soma Muscle Relaxant CYP2C19 Tizanidine Zanaflex Muscle Relaxant CYP1A2 Celecoxib Celebrex NSAID CYP2C9 Diclofenac Voltaren, Zipsor, Pennsaid, Cambia, Flector, Dyloject NSAID CYP2C9 Flurbiprofen Ocufen, Ansaid NSAID CYP2C9 Ibuprofen Advil, Motrin, Midol NSAID CYP2C9 Indomethacin Tivorbex, Indocin NSAID CYP2C9 Meloxicam Mobic NSAID CYP2C9 Naproxen Naprosyn, Anaprox, Naprelan, Aleve NSAID CYP2C9 Piroxicam Feldene NSAID CYP2C9 Sulindac Clinoril NSAID CYP2C9 Buprenorphine Butrans, Suboxone, Buprenex Opioid CYP3A4
5 Pain & Psychiatry Panel (Comprehensive) DRUG NAME TRADE NAME CATEGORY GENES RESPONSIBLE Codeine Codeine Opioid CYP2D6 Dihydrocodeine Synalgos-DC Opioid CYP2D6 Fentanyl Duragesic, Abstral, Subsys, Ionsys, Sublimaze Opioid OPRM1 Hydrocodone Lortab, Vicodin Opioid CYP2D6, OPRM1 Meperidine Demerol Opioid CYP2B6 Methadone Diskets, Dolophine, Methadose Opioid CYP2B6 Morphine MS Contin, Duramorph, DepoDur, Astramorph, Infumorph Opioid OPRM1, COMT Oxycodone Oxycontin, Percocet, Roxicodone, Oxecta Opioid CYP2D6 Tramadol ConZip, Ryzolt, Ultram Opioid CYP2D6 Ketamine Ketalar Sedative/Antidepressant - Atypical CYP2B6 Pain Panel This panel provides a comprehensive test for all the pain medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Buprenorphine Butrans, Suboxone, Buprenex CYP3A4 Carisoprodol Soma CYP2C19 Celecoxib Celebrex CYP2C9 Codeine Codeine CYP2D6 Diclofenac Voltaren, Zipsor, Pennsaid, Cambia, Flector, Dyloject CYP2C9 Dihydrocodeine Synalgos-DC CYP2D6 Fentanyl Duragesic, Abstral, Subsys, Ionsys, Sublimaze OPRM1 Fentanyl Abstral OPRM1 Flurbiprofen Ocufen, Ansaid CYP2C9 Hydrocodone Lortab, Vicodin CYP2D6, OPRM1 Ibuprofen Advil, Motrin, Midol CYP2C9 Indomethacin Tivorbex CYP2C9 Indomethacin Indocin CYP2C9 Meloxicam Mobic CYP2C9 Meperidine Demerol CYP2B6 Methadone Diskets, Dolophine, Methadose CYP2B6 Morphine MS Contin, Duramorph, DepoDur, Astramorph, Infumorph OPRM1, COMT Naproxen Naprosyn, Anaprox, Naprelan, Aleve CYP2C9 Oxycodone Oxycontin, Percocet, Roxicodone, Oxecta CYP2D6 Piroxicam Feldene CYP2C9 Sulindac Clinoril CYP2C9
6 Pain Panel Tizanidine Zanaflex CYP1A2 Tramadol ConZip, Ryzolt, Ultram CYP2D6 Psychiatry Panel This panel provides a comprehensive test for all the psychiatric medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Furthermore, this panel provides a risk assessment for Tardive Dyskinesia, Hyperprolactinemia, and weight gain for patients taking an antipsychotic medication, as well as a risk factor for inadequate antidepressant response. Alprazolam Xanax CYP3A4, 5 Amitriptyline Vanatrip, Elavil CYP2D6, CYP2C19 Amoxapine Asendin CYP2D6 Amphetamine Adderall COMT Aripiprazole Abilify CYP2D6 Atomoxetine Strattera CYP2D6
7 Psychiatry Panel Brexpiprazole Rexulti CYP2D6 Bupropion Wellbutrin, Zyban, Aplenzin ANKK1/DRD2, CYP2B6 Carbamazepine Tegretol, Carbatrol CYP3A4, 5 Chlorpromazine Thorazine CYP2D6 Citalopram Celexa CYP2C19, GRIK4, HTR2A Clobazam Onfi CYP2C19 Clomipramine Anafranil CYP2D6, CYP2C19 Clonidine Catapres, Kapvay, Duraclon, Nexiclon, FazaClo, Clozaril CYP2D6 Clonidine Kapvay CYP2D6 Desipramine Norpramine CYP2D6 Desvenlafaxine Pristiq CYP2D6 Dexmethylphenidate Focalin, Dexedrine, ProCentra, Dextrostat COMT Diazepam Diastat, Valium CYP2C19 Donepezil Aricept CYP2D6 Doxepin Silenor, Prudoxin, Zonalon CYP2D6, CYP2C19 Duloxetine Cymbalta CYP2D6, CYP1A2 Escitalopram Lexapro CYP2C19 Fluoxetine Prozac, Sarafem CYP2D6 Fluphenazine Prolixin CYP2D6 Fluvoxamine Luvox CYP2D6 Fosphenytoin Cerebyx CYP2C9 Galantamine Razadyne CYP2D6 Haloperidol Haldol CYP2D6 Iloperidone Fanapt CYP2D6 Imipramine Tofranil CYP2D6, CYP2C19 Ketamine Ketalar CYP2B6 Lacosamide Vimpat CYP2C19 Lisdexamfetamine Vyvanse COMT Lorazepam Ativan UGT2B15 Maprotiline Ludiomil CYP2D6 Methylphenidate Daytrana, Concerta, Methylin, Aptensio, Ritalin COMT, ADRA2A Midazolam Versed CYP3A4, 5 Mirtazapine Remeronsoltab, Remeron CYP2D6 Naltrexone Vivitrol, Revia OPRM1 Nefazodone Serzone CYP2D6, CYP3A4, 5 Nortriptyline Aventyl, Pamelor CYP2D6 Olanzapine Zyprexa CYP2D6, CYP1A2, HTR2C Oxazepam Serax UGT2B15 Paliperidone Invega CYP2D6 Paroxetine Paxil, Pexeva, Brisdelle CYP2D6
8 Psychiatry Panel Perphenazine Trilafon CYP2D6 Phenobarbital Luminal CYP2C19 Phenytoin Phenytek, Dilantin CYP2C9 Pimozide Orap CYP2D6 Primidone Mysoline CYP2C9, CYP2C19 Protriptyline Vivactil CYP2D6 Quetiapine Seroquel CYP3A4, 5 Risperidone Risperdal CYP2D6, HTR2C, ANKK1/DRD2 Sertraline Zoloft CYP2C19 Tetrabenazine Xenazine CYP2D6 Thioridazine Mellaril CYP2D6 Trazodone Desyrel, Oleptro CYP3A4 Trimipramine Rhotrimine, Stangyl, Surmontil CYP2D6, CYP2C19 Venlafaxine Effexor CYP2D6 Vilazodone Viibryd CYP3A4 Vortioxetine Brintellix CYP2D6 Ziprasidone Zeldox, Zipwell, Geodon CYP3A4 Zonisamide Zonegran CYP2C19 Antidepressant Panel This panel provides a test specifically for the antidepressant medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Furthermore, this panel provides a risk assessment for inadequate antidepressant response. Amitriptyline Vanatrip, Elavil CYP2D6, CYP2C19 Amoxapine Asendin CYP2D6 Citalopram Celexa CYP2C19, GRIK4, HTR2A Clomipramine Anafranil CYP2D6, CYP2C19 Desipramine Norpramine CYP2D6 Desvenlafaxine Pristiq CYP2D6 Doxepin Silenor, Prudoxin, Zonalon CYP2D6, CYP2C19 Duloxetine Cymbalta CYP2D6, CYP1A2 Escitalopram Lexapro CYP2C19 Fluoxetine Prozac, Sarafem CYP2D6 Fluvoxamine Luvox CYP2D6 Imipramine Tofranil CYP2D6, CYP2C19 Maprotiline Ludiomil CYP2D6 Mirtazapine Remeronsoltab, Remeron CYP2D6 Nefazodone Serzone CYP2D6 Nortriptyline Aventyl, Pamelor CYP2D6
9 Antidepressant Panel Paroxetine Paxil, Pexeva, Brisdelle CYP2D6 Protriptyline Vivactil CYP2D6 Sertraline Zoloft CYP2C19 Trimipramine Rhotrimine, Stangyl, Surmontil CYP2D6, CYP2C19 Venlafaxine Effexor CYP2D6 Vilazodone Viibryd CYP3A4 Vortioxetine Brintellix CYP2D6 Opioid Panel This panel provides a test specifically for the opioid pain medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Buprenorphine Butrans, Suboxone, Buprenex CYP3A4 Codeine Codeine CYP2D6 Dihydrocodeine Synalgos-DC CYP2D6 Fentanyl Duragesic, Abstral, Subsys, Ionsys, Sublimaze OPRM1 Hydrocodone Lortab, Vicodin CYP2D6, OPRM1 Meperidine Demerol CYP2B6 Methadone Diskets, Dolophine, Methadose CYP2B6 Morphine MS Contin, Duramorph, DepoDur, Astramorph, Infumorph OPRM1, COMT Oxycodone Oxycontin, Percocet, Roxicodone, Oxecta CYP2D6 Tramadol ConZip, Ryzolt, Ultram CYP2D6 Antipsychotic Panel This panel provides a test specifically for the antipsychotic medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Furthermore, this panel provides a risk assessment for Tardive Dyskinesia, Hyperprolactinemia, and weight gain for patients taking an antipsychotic medication. Aripiprazole Abilify CYP2D6 Brexpiprazole Rexulti CYP2D6 Chlorpromazine Thorazine CYP2D6 Clozapine FazaClo, Clozaril CYP2D6, CYP1A2, HTR2A, HTR2C Fluphenazine Prolixin CYP2D6 Haloperidol Haldol CYP2D6 Iloperidone Fanapt CYP2D6 Olanzapine Zyprexa CYP2D6, CYP1A2, HTR2C Paliperidone Invega CYP2D6
10 Antipsychotic Panel Perphenazine Trilafon CYP2D6 Pimozide Orap CYP2D6 Quetiapine Seroquel CYP3A4, 5 Risperidone Risperdal CYP2D6, HTR2C, ANKK1/DRD2 Tetrabenazine Xenazine CYP2D6 Thioridazine Mellaril CYP2D6 Trazodone Desyrel, Oleptro CYP3A4 Ziprasidone Zeldox, Zipwell, Geodon CYP3A4 ADHD Panel This panel provides a test specifically for the ADHD medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Amphetamine Adderall COMT Atomoxetine Strattera CYP2D6 Clonidine Catapres, Kapvay, Duraclon, Nexiclon CYP2D6 Dexmethylphenidate Focalin, Dexedrine, ProCentra, Dextrostat COMT Lisdexamfetamine Vyvanse COMT Methylphenidate Daytrana, Concerta, Methylin, Aptensio, Ritalin COMT Benzodiazepine Panel This panel provides a test specifically for the benzodiazepine medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Alprazolam Xanax CYP3A4, 5 Clobazam Onfi CYP2C19 Diazepam Diastat, Valium CYP2C19 Lorazepam Ativan UGT2B15 Oxazepam Serax UGT2B15
11 NSAID Panel This panel provides a test specifically for the NSAID pain medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Celecoxib Celebrex CYP2C9 Diclofenac Voltaren, Zipsor, Pennsaid, Cambia, Flector, Dyloject CYP2C9 Flurbiprofen Ocufen, Ansaid CYP2C9 Ibuprofen Advil, Motrin, Midol CYP2C9 Indomethacin Tivorbex, Indocin CYP2C9 Meloxicam Mobic CYP2C9 Naproxen Naprosyn, Anaprox, Naprelan, Aleve CYP2C9 Piroxicam Feldene CYP2C9 Sulindac Clinoril CYP2C9 Muscle Relaxant Panel This panel provides a test specifically for the muscle relaxant medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Carisoprodol Soma CYP2C19 Tizanidine Zanaflex CYP1A2 Anticonvulsant Panel This panel provides a test specifically for the anticonvulsant medications listed below. The report will include guidance on potentially harmful or ineffective medications, polypharmacy recommendations, potential drug-drug interactions, and dosing information when appropriate. Carbamazepine Tegretol, Carbatrol CYP3A4, 5 Fosphenytoin Cerebyx CYP2C9 Lacosamide Vimpat CYP2C19 Phenobarbital Luminal CYP2C19 Phenytoin Phenytek, Dilantin CYP2C9 Primidone Mysoline CYP2C9, CYP2C19 Zonisamide Zonegran CYP2C19
12 500 Wilson Pike Circle, Suite 360, Brentwood, TN addictionlabs.com
Medications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationDealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationMO Medicaid Foster Care Drugs FY10-FY14
MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationU T I L I Z A T I O N E D I T S
I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental
More informationUSF Health Psychiatry Clinic. New Patient Questionnaire Adult
USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days
More informationHappy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?
Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationHYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.
Pre - PA Allowance None Prior authorization is not required if prescribed by an oncologist. Prior-Approval Requirements Age 18 years of age or older Diagnosis Patient must have the following: 1. Pain,
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationPre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None
Pre - PA Allowance None Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist and/or the member has paid pharmacy claims for an oncology medication(s) in the past
More informationDuragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist
Pre - PA Allowance Quantity 30 patches every 90 days Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist Age 2 years of age or older Diagnosis Patient must have
More informationMORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)
Pre - PA Allowance Tablets & Suppositories Morphine sulfate tablets Morphine sulfate suppositories Oxymorphone tablets Hydromorphone tablets Hydromorphone suppositories 360 tablets per 90 days OR 360 suppositories
More informationCENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only
ACAMPROSATE TABLET DELAYED RELEASE ALPHA-TOCOPHEROL CAPSULES ALPRAZOLAM CONCENTRATE 1 MG/ML ALPRAZOLAM ODT TABLET 0.25MG, 0.5MG, 1MG ALPRAZOLAM ODT TABLET 2MG ALPRAZOLAM SR TABLET 24-HOUR ALPRAZOLAM TABLET
More informationNucynta IR. Nucynta IR (tapentadol immediate-release) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Nucynta IR Page: 1 of 9 Last Review Date: December 8, 2017 Nucynta IR Description Nucynta IR (tapentadol
More informationAttention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE
Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Drug List Changes - UPDATE Note: This article was previously published in the December 2014 Medicaid
More information90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR
Pre - PA Allowance 12 years of age or older Quantity Immediate-release Formulation Ultracet 720 dosage units per 90 days OR Ultram 720 dosage units per 90 days Extended-release Formulations Ultram ER 90
More informationLevorphanol. Levorphanol Tartrate. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.59 Subject: Levorphanol Page: 1 of 8 Last Review Date: March 16, 2018 Levorphanol Description Levorphanol
More informationMental Health Medications. National Institute of Mental Health. U.S. Department of HealtH and HUman ServiceS National Institutes of Health
Mental Health Medications National Institute of Mental Health U.S. Department of HealtH and HUman ServiceS National Institutes of Health Contents Mental Health Medications...1 What are psychiatric medications?...1
More informationAdult Initial Assessment / Patient Questionnaire Page 1
Page 1 Patient Name: Date: Age: Date of Birth: / / Please read the following questions and answer to the best of your ability by placing a checkmark in the appropriate boxes or filling in the blank as
More informationWelcome and thank you for choosing University of Florida Physicians!
DEPARTMENT OF PSYCHIATRY Tuesday, Division of March Child and 14, Adolescent 2017 Psychiatry 8491 NW 39 th Ave. Gainesville, FL 32606 Phone: 352-265-4357 Fax: 352-627-4163 Welcome and thank you for choosing
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationHysingla ER. Hysingla ER (hydrocodone bitartrate) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.38 Subject: Hysingla ER Page: 1 of 9 Last Review Date: September 15, 2017 Hysingla ER Description
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationPsychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More informationTRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY
TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient
More informationPatient History Form
Patient History Form Date: / / NAME: Last First Middle Birthdate: / / Age: Sex: F M Please read the following questions and answer to the best of your ability by placing a check mark in the appropriate
More informationButrans (buprenorphine patch) Description. Section: Prescription Drugs Effective Date: October 1, 2017
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Butrans Page: 1 of 9 Last Review Date: September 15, 2017 Butrans (buprenorphine patch) Description
More informationHCA BHS Prescribing Guidelines Committee - Approved Medications 2012
Amitriptyline/Perphenazine Triavil MAJOR TRANQUILIZERS Beneficiaries 10/2, 10/4, 25/2, 25/4, 50/4 Aripiprazole Abilify 2mg, 5mg, 10mg, 15mg, 20mg, 30mg Quantity Limit 31 / mo for Asenapine Saphris 5mg,
More informationThe clinical response to the same dose
Making sense of CYP2D6 and CYP1A2 genotype vs phenotype O. Greg Deardorff, PharmD, BCPP, Victoria Jenne, PharmD, MPH, BCPS, and Lauren Leonard, PharmD The clinical response to the same dose of a drug may
More informationEmbeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.39 Subject: Embeda Page: 1 of 8 Last Review Date: September 15, 2017 Embeda Description Embeda (morphine
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationBelbuca (buprenorphine buccal film) Description. Section: Prescription Drugs Effective Date: October 1, 2016
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Belbuca Page: 1 of 9 Last Review Date: September 15, 2016 Belbuca (buprenorphine buccal film)
More informationBelbuca (buprenorphine buccal film) Belbuca (buprenorphine buccal film) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Belbuca Page: 1 of 9 Last Review Date: September 15, 2017 Belbuca (buprenorphine buccal film)
More informationLevorphanol. Levorphanol Tartrate. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.59 Subject: Levorphanol Page: 1 of 8 Last Review Date: March 17, 2017 Levorphanol Description Levorphanol
More informationCENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG CLASS
ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE ODT TABLETS 15 MG REMERON SOL 90 30 MIRTAZAPINE ODT TABLETS 30 MG REMERON SOL 45 30 MIRTAZAPINE ODT TABLETS 45 MG REMERON SOL 30
More informationDemerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Meperidine Page: 1 of 7 Last Review Date: September 15, 2017 Meperidine Description Demerol (meperidine
More informationIs Your Prescription Medication Working Properly for You?
Is Your Prescription Medication Working Properly for You? The traditional approach of prescribing medication is through the trial and error method using the assumption that one size fits all. With pharmacogenetic
More informationUse Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED
Generic Drugs Are Over Brand Drugs Unless Specified As Brand ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE REMERON 30 30 MIRTAZAPINE REMERON SOLTAB 30 30 ISOCARBOXAZID TABLETS
More informationDuragesic patch. Duragesic patch (fentanyl patch) Description. Section: Prescription Drugs Effective Date: January 1, 2019
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Duragesic patch Page: 1 of 9 Last Review Date: November 30, 2018 Duragesic patch Description Duragesic patch (fentanyl
More informationPsychiatric Evaluation Intake Form
Psychiatric Evaluation Intake Form 1. Patient Contact Information Patient Name Preferred Name Last First MI Address Best contact phone number: Email address: Primary Care Physician Tel Fax Pharmacy Phone
More informationPATIENT FACE SHEET PATIENT NAME: PATIENT DOB: PATIENT PHONE #: INSURANCE: MEMBER ID: GROUP NUMBER: PATIENT ADDRESS
1 P a g e PATIENT FACE SHEET PATIENT NAME: PATIENT DOB: PATIENT PHONE #: INSURANCE: MEMBER ID: GROUP NUMBER: PATIENT ADDRESS PRIOR AUTHORIZATION #: (for office use only) INS. CONTACT NAME/ DIRECT NUMBER:
More informationPsychiatric Evaluation Intake Form
Psychiatric Evaluation Intake Form 1. Patient Contact Information Date Patient Name Address Best contact phone number Email address Emergency contact Relationship Phone No Primary Care Physician Tel Fax
More informationDuragesic patch. Duragesic patch (fentanyl patch) Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.31 Subject: Duragesic patch Page: 1 of 9 Last Review Date: September 15, 2017 Duragesic patch Description Duragesic patch (fentanyl
More informationMental Health DNA Insight WHITE PAPER
Mental Health DNA Insight WHITE PAPER JULY 2016 Mental Health DNA Insight / White Paper Mental Health DNA Insight Pathway Genomics Mental Health DNA Insight test is aimed to help psychiatrists, neurologists,
More informationDuragesic patch. Duragesic patch (fentanyl patch) Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.31 Section: Prescription Drugs Effective Date: April1, 2017 Subject: Duragesic patch Page: 1 of 10 Last Review Date: March
More informationGuidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence
Drug Gene(s)/Level of evidence Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Haloperidol CYP2D6 ( SLC6A5 ( 2D6: DPWG guidelines Reduce dose by 50% in PMs Aripiprazole
More informationSupplement: Tables and Figures
Supplement: Tables and Figures Supplement Table 1. Baseline Characteristics by Study and Efavirenz Assignment Supplement Table 2. Baseline Psychoactive Medications by Efavirenz Assignment* Supplement Table
More informationMorphine IR Hydromorphone IR Oxymorphone IR. Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone),
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.33 Subject: Morphine IR Drug Class Page: 1 of 11 Last Review Date: December 8, 2017 Morphine IR Hydromorphone
More informationMethadone. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.41 Subject: Methadone Page: 1 of 11 Last Review Date: September 15, 2017 Methadone Description Dolophine
More informationSAMPLE REPORT. Current Patient Prescriptions. Medical Name Common Name Dosage Time on Medication Ketoconazole Nizoral 400 mg 6 weeks
SAMPLE REPORT Patient: John Smith Patient Information: Patient: John Smith Patient ID: 495 DOB: Jun 09, 1977 Collection Date: Jun 21, 2017 Accession #: 6 Physician: Dr. Dan Erlanger Physician ID: 6 Report
More informationPSYCHIATRIC HISTORY 6. Are you currently seeing a therapist? (Name & contact phone#)
Cool Springs Psychiatric Group PATIENT HISTORY Patient Name Date of Birth Date form completed: *Please arrive on time and bring this form completed to your appointment to avoid any delay in seeing the
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationTarginiq ER (oxycodone/naloxone extended-release), Troxyca ER (oxycodone /naltrexone extended-release)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.44 Subject: Oxycodone Naloxone Page: 1 of 9 Last Review Date: December 2, 2016 Oxycodone Naloxone
More informationAAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
More informationOxycodone. Oxycodone IR, Oxycodone ER, OxyContin, Xtampza ER. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Oxycodone Page: 1 of 11 Last Review Date: March 17, 2017 Oxycodone Description Oxycodone IR, Oxycodone
More informationOxycodone. Oxycodone IR, Oxycodone ER, OxyContin, Xtampza ER. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Oxycodone Page: 1 of 10 Last Review Date: September 15, 2016 Oxycodone Description Oxycodone IR,
More informationThank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you.
Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you. In order to make the most of your first appointment, please come at least 30 minutes prior
More informationPHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES
PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14
More informationMethadone. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.41 Subject: Methadone Page: 1 of 13 Last Review Date: March 16, 2018 Methadone Description Dolophine
More informationOBJECTIVES PSYCHOTROPIC MEDICATIONS WHAT IS PSYCHOTROPIC MEDICATION?
PSYCHOTROPIC MEDICATIONS Sally Davies, Ph.D., HSPP Licensed Psychologist OBJECTIVES 1. Identify psychotropic medications and the typical usages 2. Identify effective methods for the practical application
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationAHCCCS BEHAVIORAL HEALTH DRUG LIST EFFECTIVE OCTOBER 1, 2016
Generic Drugs Are Preferred Over Brand Name Drugs Unless Specified As Brand Only Federally Reimbursable Drugs Not Listed On The AHCCCS Drug List Are Available Through Prior Authorization Effective Date
More informationBELBUCA (buprenorphine buccal film)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Belbuca is indicated for the management of chronic pain severe enough to require daily, aroundthe-clock, long-acting opioid treatment for which alternative
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More information1911 Keller Andrews Road Sanford, NC
1911 Keller Andrews Road Sanford, NC 27330 919.777.9355 www.wellcenteredcounseling.com Well CENTERED Today's date: Patient Information: Individual Name: Date of Birth: Age: (first) (last) Gender M/F Ethnicity
More informationMental Health Intake Form
Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )
More informationPsychiatric Intake Form (Please note: if you are not comfortable answering any of the following questions, feel free to leave the space blank)
Past Psychiatric History: What issues or symptoms bring you to this practice? When did these symptoms start? Are the symptoms constant or intermittent? List any previous psychiatric conditions you have
More informationNEW PATIENT INTAKE FORM
NEW PATIENT INTAKE FORM Please fill out the following form to the best of your ability. Some sections may not apply to you. We will discuss your responses in greater detail during your first appointment.
More informationXartemis XR (oxycodone / acetaminophen extended release)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Xartemis XR is a combination of oxycodone and acetaminophen in a dosage formulation to deliver both immediate pain relief, in less than an hour, and extended-release
More information2015 Update on Psychotropics
2015 Update on Psychotropics Jeffrey T. Apter, M.D. August 2015 Princeton Medical Institute 256 Bunn Drive, Suite 6, Princeton NJ (609) 921-6050 Learning Objectives Upon completion of this session, participants
More informationBriefly state the reason for this evaluation: Patient s Name: Sex: Male/Female (circle one) Date of Birth: Age: Patient s Social Security #
Psychiatric Evaluation Form After Hours Psychiatry, PLLC Aaron Alaniz, M.D. 25722 Kingsland Blvd, Suite 202 Katy, TX 77494 T: 281-978-2515 F: 281-978-2895 Briefly state the reason for this evaluation:
More informationMay 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator:
May 22, 2013 DAL: DAL 13-11 SUBJECT: Hot Weather Advisory Dear Administrator/Operator: The New York State Department of Health would like to remind you of our expectations regarding the protection of Adult
More informationGenetic Testing Patient Guide
Genetic Testing Patient Guide Over the last decade, pharmacogenetics has become increasingly significant to clinical practice. Psychiatric patients, in particular, may benefit from pharmacogenetic testing
More informationSteps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
More informationIR PROCEDURE REFERENCE GUIDE
IR PROCEDURE REFERENCE GUIDE Procedure Scan Involvement Preparation Length For Procedure CT CT BIOPSIES/ DRAINS Done per Radiologist in CT (Must be pre-approved by Radiologist) NPO after midnight or 6
More informationMental Health Intake Form
38600 Van Dyke Ave., Suite 200 Sterling Heights, MI 48313 Phone: (586) 933-5395 Fax: (586) 935-0159 Mental Health Intake Form Please complete all information on this form and bring it to the first visit.
More informationTitle 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 05/01/2015
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 05/01/2015 Effective April 1, 2014, Mercy Maricopa Integrated Care began operations as the Regional Behavioral Health Authority
More informationOXYCODONE IR (oxycodone)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Oxycodone hydrochloride, a pure opioid agonist, is used in the treatment of moderate to severe pain (1-2). The precise mechanism of action is unknown; however,
More informationRxIGHT RESULTS REPORT Pharmacogenetics Test Results
Authorizing Physician: Dr. Denis Patterson, DO Patient Name: John Williams Account ID: 123456 Patient SSN: xxx-xx-xxxx Requisition ID: RXT00006 Patient DOB: 12/1/1949 Collected: Received: Analyzed: Completed:
More informationNew Patient Information - Adolescent
Scanned Ages 12-17 Dear Parent: To help your clinician understand and help your child, please answer the questions on this form and bring it with you to your child s first appointment. Please print using
More informationRATIONALE FOR INCLUSION IN PA PROGRAM
RATIONALE FOR INCLUSION IN PA PROGRAM Background Tramadol is a centrally acting synthetic opioid analgesic used to treat moderate to moderately severe chronic pain in adults. Along from analgesia, tramadol
More informationABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR
ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if
More informationAll formulary medications available in generic form are supplied in generic form. Requests for brand name preparations must get prior authorization.
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 10/01/2018 About the Behavioral Health Drug List The Mercy Care behavioral health drug list includes all of the behavioral health
More informationTitle 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 4/01/2018
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 4/01/2018 Effective April 1, 2014, Mercy Maricopa Integrated Care began operations as the Regional Behavioral Health Authority
More informationmed ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors.
med ed Dr. Andrea Murphy, Assistant Professor, School of Nursing, Dalhousie University; Research Associate, Sun Life Financial Chair in Adolescent Mental Health Dr. David Gardner, Associate Professor,
More informationTitle 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 01/01/2017
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 01/01/2017 Effective April 1, 2014, Mercy Maricopa Integrated Care began operations as the Regional Behavioral Health Authority
More informationAvoid paying too much for your prescriptions
Quality health plans & benefits Healthier living Financial well-being Intelligent solutions 2017 Aetna Rx Step Program Medicine List Avoid paying too much for your prescriptions It s important to try to
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More information